IRIS UniCatt

Pierconti, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.949
EU - Europa 4.027
AS - Asia 3.825
SA - Sud America 774
AF - Africa 115
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 13.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.816
SG - Singapore 1.720
IT - Italia 1.135
CN - Cina 855
DE - Germania 693
SE - Svezia 679
BR - Brasile 638
VN - Vietnam 401
FR - Francia 316
PL - Polonia 310
IN - India 182
UA - Ucraina 179
GB - Regno Unito 161
IE - Irlanda 149
ID - Indonesia 120
JP - Giappone 116
FI - Finlandia 91
RU - Federazione Russa 79
NL - Olanda 70
HK - Hong Kong 69
CA - Canada 64
TR - Turchia 63
BD - Bangladesh 60
AR - Argentina 50
MX - Messico 41
BE - Belgio 35
IQ - Iraq 35
ZA - Sudafrica 32
ES - Italia 28
KR - Corea 27
AT - Austria 26
EC - Ecuador 22
PK - Pakistan 21
CI - Costa d'Avorio 18
CO - Colombia 17
IR - Iran 17
MA - Marocco 17
UZ - Uzbekistan 16
VE - Venezuela 16
JO - Giordania 14
SA - Arabia Saudita 14
CH - Svizzera 12
LT - Lituania 11
AZ - Azerbaigian 10
PH - Filippine 10
AE - Emirati Arabi Uniti 9
NP - Nepal 9
KE - Kenya 8
OM - Oman 8
PY - Paraguay 8
UY - Uruguay 8
AU - Australia 7
CR - Costa Rica 7
DZ - Algeria 7
EG - Egitto 7
LV - Lettonia 7
PE - Perù 7
CL - Cile 6
LB - Libano 6
NO - Norvegia 6
TN - Tunisia 6
ET - Etiopia 5
LK - Sri Lanka 5
NI - Nicaragua 5
SN - Senegal 5
AL - Albania 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
MD - Moldavia 4
MY - Malesia 4
PT - Portogallo 4
RO - Romania 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
EU - Europa 3
KG - Kirghizistan 3
KW - Kuwait 3
MM - Myanmar 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
TH - Thailandia 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
Totale 13.691
Salva come PNG Salva come JPEG
Città #
Singapore 984
Chandler 570
Ashburn 540
San Jose 469
Warsaw 289
Beijing 182
Ho Chi Minh City 154
Milan 148
Dublin 147
Rome 142
Los Angeles 133
Ann Arbor 127
New York 122
Fairfield 117
San Mateo 112
The Dalles 111
Wilmington 105
Jacksonville 104
Lauterbourg 103
Jakarta 102
Hanoi 96
Nanjing 94
Seattle 94
Frankfurt am Main 90
Tokyo 82
Chicago 76
Houston 74
Cambridge 69
Woodbridge 66
Munich 64
São Paulo 64
Hefei 62
Hong Kong 61
Dearborn 59
Boston 58
Hyderabad 58
Moscow 58
Princeton 52
Council Bluffs 46
Helsinki 43
Redmond 43
Izmir 42
Bremen 40
Santa Clara 40
Dallas 39
Nanchang 36
Marseille 34
Orem 34
Cattolica 31
Stockholm 31
Brussels 29
Kadoma 28
Lawrence 28
Verona 26
Buffalo 24
Nürnberg 24
Seoul 24
Shanghai 24
Bologna 23
Naples 23
Florence 22
Belo Horizonte 21
Denver 21
Johannesburg 21
Kent 21
London 21
Montreal 21
Redwood City 21
Shenyang 19
Abidjan 18
Bari 18
Da Nang 18
Enterprise 18
Mountain View 18
Toronto 18
Amsterdam 17
Brasília 17
Düsseldorf 17
Kunming 17
Nuremberg 17
Chennai 16
Hangzhou 16
Manchester 16
Palermo 16
Paris 16
Vienna 16
Atlanta 15
Brooklyn 15
Catania 15
Dhaka 15
Guangzhou 15
Mumbai 15
Tianjin 15
Baghdad 14
Phoenix 14
Rio de Janeiro 14
Tashkent 14
Amman 13
Falls Church 13
Haiphong 13
Totale 7.427
Salva come PNG Salva come JPEG
Nome #
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 907
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 415
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 320
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 274
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 252
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 237
Metabolic reprogramming by malat1 depletion in prostate cancer 225
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 208
Incidental finding of right renal venous aneurysm in a patient with symptomatic ipsilateral renal carcinoma: a case report 190
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 183
MECKEL'S DIVERTICULUM FINDINGS ON TC-99 RED BLOOD SCINTIGRAPHY IN A BLEEDING LEUKEMIC PATIENT CONFIRMED BY TC-99 PERTENECHTATE SCINTIGRAPHY 176
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 173
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 172
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 169
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 167
Bladder and prostate metastasis from small cell lung cancer: a rare entity 165
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 160
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 158
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 148
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 148
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. 148
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 147
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 142
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 139
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 138
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 137
Methylation study of the Paris system for reporting urinary (TPS) categories 134
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 131
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 130
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 130
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 130
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 130
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 129
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 128
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 126
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 126
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 124
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 124
Olfactory receptors in semen and in the male tract: From proteome to proteins 124
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 123
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 123
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma. 123
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 122
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 122
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma 122
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 121
Biomarkers of response to advanced prostate cancer therapy 121
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 120
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 120
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 120
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology 119
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 118
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 118
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making 114
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 112
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 111
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy) 109
p53 expression in cytology samples may represent a marker of early-stage cancer 108
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 108
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 108
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 106
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 105
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 105
Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy 102
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 102
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 102
Giant spermatic cord liposarcoma 101
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 100
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 100
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 100
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 99
Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario. 99
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 99
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 98
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 98
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 98
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 96
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 96
Proteomics for the identification of biomarkers in testicular cancer–review 96
Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications 93
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 92
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 91
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 90
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 89
Mesenchymal differentiation of glioblastoma stem cells 88
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 88
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 87
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 86
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 86
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 84
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 83
Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B-cell lymphoma: A case report 81
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 78
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 78
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma 77
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 76
First-line ICIs in renal cell carcinoma 68
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 68
Totale 13.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 0 0 0 0 0 123 18
2021/2022860 76 39 27 80 70 28 38 125 41 57 131 148
2022/20231.769 249 232 139 261 92 210 84 130 179 69 83 41
2023/20241.194 79 227 62 75 89 158 93 61 24 84 104 138
2024/20252.177 70 61 196 94 175 128 75 101 243 247 448 339
2025/20265.251 743 187 313 690 969 285 1.005 296 377 362 24 0
Totale 13.923